Skip Nav Destination
Issues
December 2010
ISSN 0030-2414
EISSN 1423-0232
Journal Name Change
Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.
Oncology 2010, Vol. 79, No. 1-2
Editorial
Review
Trimodal Therapy for Inflammatory Breast Cancer: A Surgeon’s Perspective
Subject Area:
Oncology
Benjamin D. Li; Mark A. Sicard; Fred Ampil; Fleurette Abreo; David Lilien; Quyen D. Chu; Gary V. Burton
Oncology (2010) 79 (1-2): 3–12.
https://doi.org/10.1159/000318529
Women and Bone Health: Maximizing the Benefits of Aromatase Inhibitor Therapy
Subject Area:
Oncology
Oncology (2010) 79 (1-2): 13–26.
https://doi.org/10.1159/000314997
Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis
Subject Area:
Oncology
Oncology (2010) 79 (1-2): 27–38.
https://doi.org/10.1159/000314980
Clinical Study
Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases
Subject Area:
Oncology
Eiichiro Suzuki; Junji Furuse; Masafumi Ikeda; Takuji Okusaka; Kohei Nakachi; Shuichi Mitsunaga; Hideki Ueno; Chigusa Morizane; Shunsuke Kondo; Satoshi Shimizu; Yasushi Kojima; Atsushi Hagihara
Oncology (2010) 79 (1-2): 39–45.
https://doi.org/10.1159/000318020
Palliative Chemotherapy Does Not Improve Survival in Metastatic Esophageal Cancer
Subject Area:
Oncology
Oncology (2010) 79 (1-2): 46–54.
https://doi.org/10.1159/000318029
Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors
Subject Area:
Oncology
Kazuyoshi Motomura; Makoto Ishitobi; Yoshifumi Komoike; Hiroki Koyama; Hideki Nagase; Hideo Inaji; Shinzaburo Noguchi
Oncology (2010) 79 (1-2): 55–61.
https://doi.org/10.1159/000319540
Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation
Subject Area:
Oncology
Oncology (2010) 79 (1-2): 62–66.
https://doi.org/10.1159/000319548
Stop and Go FOLFOX plus Bevacizumab Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer
Subject Area:
Oncology
Oncology (2010) 79 (1-2): 67–71.
https://doi.org/10.1159/000319549
Clinical Translational Research
Cisplatin Application in Pregnancy: First in vivo Analysis of 7 Patients
Subject Area:
Oncology
Simone Marnitz; Christhardt Köhler; Peter Oppelt; Alexander Schmittel; Giovanni Favero; Kati Hasenbein; Achim Schneider; Maurie Markman
Oncology (2010) 79 (1-2): 72–77.
https://doi.org/10.1159/000320156
Clinical Study
Prognostic Model to Predict Outcomes in Non-Small Cell Lung Cancer Patients with Erlotinib as Salvage Treatment
Subject Area:
Oncology
Oncology (2010) 79 (1-2): 78–84.
https://doi.org/10.1159/000320190
Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment
Subject Area:
Oncology
Marcus Alexander Wörns; Marcus Schuchmann; Christoph Düber; Gerd Otto; Peter Robert Galle; Arndt Weinmann
Oncology (2010) 79 (1-2): 85–92.
https://doi.org/10.1159/000320363
Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation
Subject Area:
Oncology
Panagiotis Samaras; Elefteri M. Buset; Raffaele Daniele Siciliano; Sarah R. Haile; Ulf Petrausch; Axel Mischo; Hanspeter Honegger; Bernhard C. Pestalozzi; Urs Schanz; Georg Stussi; Rolf A. Stahel; Alexander Knuth; Christoph Renner; Frank Stenner-Liewen
Oncology (2010) 79 (1-2): 93–97.
https://doi.org/10.1159/000320604
Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer
Subject Area:
Oncology
Alfonso Sánchez-Muñoz; César Mendiola; Elisabeth Pérez-Ruiz; César A. Rodríguez-Sánchez; José Miguel Jurado; Lorenzo Alonso-Carrión; Ismael Ghanem; Guillermo de Velasco; Cristina Quero-Blanco; Emilio Alba
Oncology (2010) 79 (1-2): 98–104.
https://doi.org/10.1159/000320602
Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences
Subject Area:
Oncology
Bala Basak Oven Ustaalioglu; Ahmet Bilici; Umut Kefeli; Mesut Şeker; Emre Yildirim; Taflan Salepci; Mustafa Oncel; Metin Kement; Mahmut Gumus
Oncology (2010) 79 (1-2): 105–111.
https://doi.org/10.1159/000320162
Reducing the Worldwide Burden of Cancer
Assessment of Fatigue in Cancer Patients and Community Dwellers: Validation Study of the Filipino Version of the Brief Fatigue Inventory
Subject Area:
Oncology
Content Sponsor:
Reducing the Worldwide Burden of Cancer
Tito R. Mendoza; Adriano V. Laudico; Xin Shelley Wang; Hong Guo; Maria Lourdes Matsuda; Victor D. Yosuico; Edilberto P. Fragante; Charles S. Cleeland
Oncology (2010) 79 (1-2): 112–117.
https://doi.org/10.1159/000320607
Review
Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer
Subject Area:
Oncology
Oncology (2010) 79 (1-2): 118–128.
https://doi.org/10.1159/000314993
Clinical Study
A Single-Arm Phase II Trial of First-Line Paclitaxel in Combination with Lapatinib in HER2-Overexpressing Metastatic Breast Cancer
Subject Area:
Oncology
Agnieszka Jagiello-Gruszfeld; Sergei Tjulandin; Natalya Dobrovolskaya; Alexey Manikhas; Tadeusz Pienkowski; Michelle DeSilvio; Mona Ridderheim; Rowena Abbey
Oncology (2010) 79 (1-2): 129–135.
https://doi.org/10.1159/000318043
Oxaliplatin-Free Interval as a Risk Factor for Hypersensitivity Reaction among Colorectal Cancer Patients Treated with FOLFOX
Subject Area:
Oncology
Yukiko Mori; Takafumi Nishimura; Toshiyuki Kitano; Ken-ichi Yoshimura; Shigemi Matsumoto; Masashi Kanai; Megumi Hazama; Hiroshi Ishiguro; Satoshi Nagayama; Kazuhiro Yanagihara; Satoshi Teramukai; Tsutomu Chiba; Yoshiharu Sakai; Masanori Fukushima
Oncology (2010) 79 (1-2): 136–143.
https://doi.org/10.1159/000320613
High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome
Subject Area:
Oncology
Bahir Aldulaymi; Per Byström; Åke Berglund; Ib J. Christensen; Nils Brünner; Hans J. Nielsen; Bengt Glimelius
Oncology (2010) 79 (1-2): 144–149.
https://doi.org/10.1159/000320686
Rechallenge with Platinum plus Fluoropyrimidine +/– Epirubicin in Patients with Oesophagogastric Cancer
Subject Area:
Oncology
Oncology (2010) 79 (1-2): 150–158.
https://doi.org/10.1159/000322114